Last updated: September 2020
Karine Lamiraud
French citizen
General Information
Office Address: ESSEC Business School Avenue Bernard Hirsch B.P. 50105 95021 Cergy Pontoise cedex France Phone: + 33 34 43 36 65
E-Mail: [email protected]
Education 2004 Ph.D. Economics PSE (Paris School of Economics) and University of Lausanne Advisors: Pierre-Yves Geoffard and Alberto Holly 1998 M.A. Economics PSE (Paris School of Economics) 1997 M.Sc Management HEC School of Management, Grande Ecole, Paris 1997 M.Sc International Management Wirtschaftsuniversität,Vienna, Community of European Management Schools(CEMS) programme 1991 - 1993 Classes préparatoires HEC Lycée Louis-Le-Grand, Paris
Employment 2017 - present Professor of Economics, ESSEC Business School, Paris 2016 - present Chaired Professor of the ESSEC Chair of Innovation and Health 2015 - present Associate Dean of Faculty, ESSEC Business School, Paris 2011 - 2017 Associate Professor of Economics, ESSEC Business School, Paris 2010 - 2011 Assistant Professor of Economics, ESSEC Business School, Paris 2005 - 2010 Assistant Professor of Economics, HEC Lausanne, University of Lausanne 2002 - 2005 Research &Teaching Assistant, University Hospital (CHUV) & HEC Lausanne 2002 - 2003 Consultant in Health Economics, CLP Santé, Paris 1999 - 2002 Economist, GlaxoSmithKline, Economic Affairs and Pricing Department, Paris 1995 - 1996 Junior Product Manager (Prozac), Eli Lilly, Marketing Department, Paris
Visiting positions and Other Affiliations June-August 2019 Visiting Scholar (appointed), Stanford University, Department of Health (sabbatical) Research and Policy, https://med.stanford.edu/hrp.html
Feb-March 2014 Visiting Scholar (appointed), Stanford University, Department of Health Research and Policy
2011 - present Member of THEMA, University of Cergy-Pontoise
2010 - 2012 Visiting Professor (appointed), University of Lausanne
Page 1 sur 11 Last updated: September 2020
December 2009 Visiting Fellow, Newcastle University
August Visiting Assistant Professor, Harvard University, Department of Health 2006,2007, 2008 Care Policy (HCP)
October 2006 Visiting Fellow, National Bureau of Economic Research (NBER), New York July 2008 branch office
June-October Visiting Assistant Professor (appointed), Harvard University, Department of 2005 Health Care Policy (HCP) (Fulbright Fellowship)
Awards and Honors 2009 Award for ‘best paper’ published in Health Economics during the period 2006-07 2006, 2007, 2008 Marie-Curie Training Programme in applied Health Economics (organized by the University of York) 2005 Fulbright Fellowship, French-American Commission 2005 Swiss National Science Foundation Fellowship for exchange programmes 2005 Dissertation award from HEC Lausanne
Teaching ESSEC Business School (current position) Business Economics (M.Sc), Paris and Singapore Microeconomics (M.Sc), Paris Health Economics (M.Sc), Paris Evaluation methods of therapeutic actions, Executive Education, Paris and Singapore Health Care Financing, Executive Education, Paris and Singapore
HEC Lausanne (past position) Health Care Landscape (EMBA in Health Care Management) Topics in Health Insurance (MAS in Health Economics and Management) Risk and Insurance (BA.) Health Economics (M.Sc in Economics)
Faculty of Biology and Medicine, University of Lausanne (past position) Introduction to Health Economics
IESE (Barcelona and Madrid) (invited lectures) Topics in Health Insurance
Academic responsibilities 2013 - present Academic Co-Director of the SMIS program (Executive Master Strategy and Management of Health Industries)
Research Research interests: Health Economics and Applied Econometrics Competition and Consumer choices in Health Insurance Markets Valuation Methods of Health Care Strategies
Page 2 sur 11 Last updated: September 2020
Health Economics in Developing Countries Economics of HIV/AIDS Diffusion and Costs of Health Technologies
Published Articles (refereed journals) 15. Lamiraud K, Stadelmann P. (2020). Switching Costs in Competitive Health Insurance Markets: The Role of Insurers’ Pricing Strategies. Health Economics 29:992-1012.
14. Lamiraud K, Vranceanu R (2018). Group gender composition and economic decision-making: Evidence from the Kallystée business game. Journal of Economic Behavior & Organization 145: 294-305.
13. Lamiraud K, Lhuillery S (2016). Endogenous Technology Adoption and Medical Costs. Health Economics 25: 1123-1147.
12. Lamiraud K, Oxoby R, Donaldson C (2016). Incremental willingness to pay: a theoretical and empirical exposition. Theory and Decision 80:101-123.
11. Nicod E, Stringhini S, Marques-Vidal P, Paccaud F, Waeber G, Lamiraud K, Vollenweider P, Bochud M (2014). Association of education and receiving social transfers with allostatic load in the Swiss population-based CoLaus study. Preventive Medicine 63: 63-71.
10. Gossec L, Berenbaum F, Chauvin P, Lamiraud K, Russo-Marie F, Joubert JM, Saraux A (2014). Reporting of patient-perceived impact of rheumatoid arthritis and spondyloarthritis over 10 years: a systematic literature review. Rheumatology 53 (7): 1274- 1281.
9. Dormont B, Geoffard PY, Lamiraud K (2012). Assurance maladie en Suisse : les assurances supplémentaires nuisent-elles à la concurrence sur l’assurance de base ? Economie et Statistiques 455-456: 71-87.
8. Lamiraud K, Moatti JP, Raffi F, Carrieri P, Protopopescu C, Michelet C, Schneider L, Collin F, Leport C, Spire B (2012). Adherence to and effectiveness of Highly Active Antiretroviral Treatment for HIV infection: assessing the bidirectional relationship. Medical Care 50: 410-418.
7. Saffer H, Lamiraud K (2012). The effect of hours of work on social interaction. Review of Economics of the Household 10: 237-258 (also available as NBER Working paper #13743, Januray 2008)
6. Lamiraud K, Holly A, Burnand B, Juillerat P, Wietlisbach V, Froehlich F, Gonvers JJ, Vader JP (2010). The effect of non-medical factors on variations in the performance of colonoscopy among different health care settings. Medical Care 48(2): 101-109.
5. Lamiraud K, Von Bremen K, Donaldson C (2009). The impact of information on patient preferences in different delivery patterns: prescription versus OTC. Health Policy 93 (2-3): 102–110.
4. Dormont B, Geoffard PY, Lamiraud K (2009). The influence of supplementary health insurance on switching behaviour: evidence from Swiss data. Health Economics 18(11): 1339-1356.
Page 3 sur 11 Last updated: September 2020
3. Frank RG, Lamiraud K (2009). Choice, Price competition and Complexity in Markets for Health Insurance. Journal of Economic Behavior and Organization 71(2): 550-562. (also available as NBER Working paper #13817, February 2008)
2. Lamiraud K, Geoffard PY (2007). Therapeutic non adherence: a rational behaviour revealing patient preferences? Health Economics 16(11):1185-1204. This article was awarded the “Best Paper” prize of papers published in Health Economics in 2006-2007.
1. Lamiraud K, Moatti JP (2006). Economic implications of non-adherence to HAART in HIV patients. Expert Opinion on Pharmacotherapy 7 (2): 135-143.
Chapters in a book 5. Lamiraud K (2014). Switching Costs in Competitive Health Insurance Markets. In: Anthony J. Culyer (ed.), Encyclopedia of Health Economics, Vol 3. San Diego: Elsevier; 2014. pp. 375-381.
4. Moschetti K, Lamiraud K, Holly A, O’Donnell O (2011). Does Poor Childhood Help Explain Health Care Utilisation and Payments in Middle and Old Age? In: The Individual and the Welfare State. Life Histories in Europe, Axel Börsch-Supan, Martina Brandt, Karsten Hank and Mathis Schröder (eds). Springer: Heidelberg.
3. Lamiraud K (2011). Le rôle des consommateurs dans la concurrence des systèmes d'assurance santé: l’exemple de la Suisse. In La régulation des secteurs de la Santé. Thèmes et commentaires. Droit et Economie de la Régulation, MA Frison-Roche (ed). Presses de Sciences Po et Dalloz: Paris.
2. Holly A, Lamiraud K, Moschetti K, Yalcin T (2008). Changes in health out-of-pocket (OOP) payments and health care utilization in the early post retirement period. In Health, Ageing and Retirement in Europe (2004-2007) – Starting the longitudinal dimension, Börsch-Supan A, Brugiavini A, Jürges H, Kapteyn A, Mackenbach J, Siegrist J, Weber G (eds). Mannheim: MEA.
1. Holly A, Lamiraud K, Chevrou-Severac H, Yalcin T (2005). Out-of-pocket payments for health care expenditures. In Health, Ageing and Retirement in Europe – First results from the Survey of Health, Ageing and Retirement in Europe, Börsch-Supan A, Brugiavini A, Jürges H, Mackenbach J, Siegrist J (eds). Mannheim: MEA.
Working Papers (unpublished papers) Abul-Naga R, Lamiraud K (2010). Catastrophic Health Expenditure and Household Well Being. ESSEC Working Papers.
Scheil-Adlung X, Booysen F, Lamiraud K, Reynaud E, Juetting J, Asfaw A, Xu K, Carrin G, Chatterji S, Evans D, James C, Muchiri S (2006). What is the impact of social health protection on access to health care, health expenditure and impoverishment ? A comparative analysis of three African countries. World Health Organization EIP/HSP/DP.06. Available at SSRN: http://ssrn.com/abstract=916703
Lamiraud K, Booysen F, Scheil-Adlung X (2005). The Impact of Social Health Protection on Access to Health Care, Health Expenditure and Impoverishment: A Case Study of South Africa. International Labour Office, Department of social security, Extension of Social Security 23, Available at SSRN: http://ssrn.com/abstract=822704
Page 4 sur 11 Last updated: September 2020
Other Papers and Published Abstracts Browne J, Sørensen T, Bonati M, Edwards N, Gunning-Schepers L, Keil P, Lamiraud K, Lange P, Olauson A, Olsen J, Sans S, Sauer F, Scintee SG, Wysocki MJ (2013). I finanziamenti UE su Ricerca in Salute Pubblica. Ricerca e Pratica 29(4): 173-175.
Gossec L, Berenbaum F, Chauvin P, Lamiraud K, Russo-Marie F. Peurs et croyances des patients souffrant de polyarthrite rhumatoïde et de spondylarthrites: Une revue systématique de la littérature (2012). Rev Rhumatisme (79): A133-A334.
Lilliu H, Le Pen C, Lamiraud K, Wittenberg W (2003). A Cost-Effectiveness Analysis of ACE Inhibitor Trandolapril as a Preventative Treatment of Heart-Failure Progression. Value in Health 6 (6) : 631.
Lilliu H, Le Pen C, Lamiraud K, Wittenberg W (2003). A Cost and Cost-Effectiveness (CE) Analysis of Angiotensin Converting Enzyme (ACE) Inhibitor Trandolapril in the Treatment of Post Infarction in the US. Value in Health 6 (3) : 320-321.
Research summaries/ Media coverage Obamacare’s Inertia Problem (December 8th 2014). The New Yorker (by James Surowiecki). http://www.newyorker.com/magazine/2014/12/08/obamacares-inertia-problem
L’observance: un défi incontournable. Décembre 2014. Pharmaceutiques.
It is not work that keeps people from interacting (2013). Stats and Curiosities: From Harvard Business Review page 61 (written and edited by Andrew O’Connell). Harvard Business Review Press.
Undercover Economist (March 8th 2008). Financial Times (by Tim Harford). https://next.ft.com/content/9f5c8544-e8c3-11dc-913a-0000779fd2ac
Choice and Price Competition in Health Insurance Markets (2008). NBER Bulletin on Aging and Health, No. 2. http://www.nber.org/aginghealth/2008no2/w13817.html
Making Time for Friends (February 20th2008).VoxEU.org. http://www.voxeu.org/index.php?q=node/945
Dissertation An economic and econometric analysis of patient adherence behaviour: implementation on trial clinical data in HIV disease (in French) (2004). http://www.chuv.ch/bdfm/cdsp/TheseLamiraud.pdf
Research grants 2008 – 2011 Swiss National Science Foundation, principal investigator. Health Care Costs and the Diffusion of Medical Technologies: Evidence on Swiss Data (174 484 CHF)
2006 – 2010 ANRS (French national agency for research on AIDS and viral hepatitis, Agence Nationale de Recherches sur le Sida et les Hépatites Virales), principal investigator. A longitudinal analysis of adherence to antiretroviral therapies in HIV disease in a medical practice framework. Joint work with INSERM U379, Marseille (30 000 euros)
Page 5 sur 11 Last updated: September 2020
2005 – 2007 Swiss National Science Foundation, co-investigator (principal investigators: B Dormont, PY Geoffard). Evaluation of competition on health insurance markets: the Swiss case (140 816 CHF)
Dissertation committee 2019 Arthur Souletie, Ph.D. Economics, Paris School of Economics 2018 Amélie Adeline, Ph.D. Economics, University of Cergy-Pontoise 2013 Mercedes Velles, Ph.D. Economics, University of Tor Vergata, Roma 2013 Marc Perronnin, Ph.D. Economics,University Paris-Dauphine 2010 Christian Viladent, Ph.D. Economics, University of Lausanne 2008 Christophe Pinget, Ph.D. Economics, University of Lausanne
Presentations “The Impact of DRG Payment on the Diffusion of Medical Innovation/ CT Scanners” • 2nd Asian Workshop on Econometrics and Health Economics, Otaru, Hokkaido, December 2019
“Balance Billing as a Signaling Device” • 20th European Health Economics Workshop, Verona, May 2019
“Strategic pricing behaviors in the presence of consumer inertia: the case of health insurance” • Waseda-Keio Mini-Conference on Economics of Healthcare Systems, Tokyo, December 2018 • Italian Health Economics Association 23rd Annual Conference, Napoli, September 2018 • Congress of the International Health Economics Association (iHEA), Boston, July 2017 • University Paris-Dauphine, Paris, January 2013 • NBER Summer Institute, Boston, July 2011
“French perspectives on healthcare funding and priority setting” • Medicine, Markets and Morals Network, Birmingham, October 2015
“Incremental versus standard WTP: an application to out-of-hours and emergency care” • Journée de la Chaire Santé, Université Paris-Dauphine, March 2015 • 2nd Workshop on Non-Market Valuation, Aix-en-Provence, June 2014 • 9th Congress of the International Health Economics Association (iHEA), Sydney, July 2013 • British-French HESG-CES workshop, Aix-en-Provence, January 2012
"New Technologies and medical costs: a Swiss perspective at the canton level" • 6th Australian Workshop on Econometrics & Health Economics, Melbourne, April 2015 • Service de la Santé Publique, Canton de Vaud, Switzerland, Invited Seminar, October 2010 • University of Lugano, Switzerland, Invited Seminar, May 2010 • 7th Congress of the International Health Economics Association (iHEA), Beijing, July 2009 • NBER Summer Institute, Boston, July 2008
" The determinants of user innovation in medical imaging devices" • DRUID conference, Singapore, February 2016 • Schumpeter 2010, Aalborg University, Denmark, June 2010 • Open and User Innovation conference, MIT, Sloan School, Cambridge MA, August 2010
Page 6 sur 11 Last updated: September 2020
• 7th Annual International Open and User Innovation Workshop, Hamburg University of Technology (TUHH), Kühne School of Logistics, June 2009
" The Competition in health insurance markets: do consumers vote with their feet?The case of Switzerland" • Working Group LEEM-Groupama-Cabinet Tilder, Paris, December 2016 •The Working Group on Risk – CREAR, ESSEC Business School, December 2014 • IESE Business School, Invited Seminar, Barcelona, May 2013 • MGEN,Board of Directors, Paris, September 2012 • IESE Business School, Invited Seminar, Madrid, June 2012 • ENS Cachan, Invited Seminar, Paris, May 2012 • AXA,Board of Directors, Paris, March 2011 • IESE Business School, Invited Seminar,New York, June 2010 • Ecole des Hautes Etudes en Santé Publique (EHESP), Invited Seminar, Rennes, November 2010 • Mutalité Française,Board of Directors, Nantes, March 2010
“Economic analysis of the development of antibacterial resistance” • Institut Pasteur/INSERM workshop « Bacterial evasion to anti-infectives: from gene to public health », Paris, January 2012
" Does culture matter for health?" • 8th Congress of the International Health Economics Association (iHEA), Toronto, July 2011
" The relationship between basic and supplementary insurance in Swiss health care markets" • 8th European Conference on Health Economics (ECHE), Helsinki, July 2010
" Does Poor Childhood Health Explain Increased Health Care Utilisation and Payments in Middle and Old Age?" • Share Conference, Paris, March 2010
" Embedded demand for new technologies: evidence from CT and PET scanners" • DIME Conference organized by KITeS - CESPRI – Università Bocconi, Milan, Milan, October 2008 • Thematic Meeting of the French Economic Association (AFSE), Firms, Markets and Innovation, Sophia Antipolis, June 2009
"Changes in health OOP payments and health care utilization in the early post retirement period" • Share Conference, Antwerp, February 2008
"The relationship between high adherence and treatment efficacy: an econometric approach" • 12th International Workshop on HIV Observational Databases, Malaga, March 2008
"Price competition and Complexity in Markets for Health Insurance" • NBER Summer Institute, Boston, July 2007 • 8th European Health Economic Workshop (EHEW), Magdeburg, April 2007 • 6th European Conference on Health Economics (ECHE), Budapest, July 2006
"The influence of supplementary health insurance on switching behaviour: evidence on Swiss data" • Meeting of the Swiss Society of Economics and Statistics, Lausanne, March 2008
Page 7 sur 11 Last updated: September 2020
•16th European workshop on Econometrics and Health Econometrics, Bergen, September 2007 • 6th European Conference on Health Economics (ECHE), Budapest, July 2006
"Catastrophic Health Expenditure and Household Well-Being" • 10th European Health Economic Workshop (EHEW), Lisbon, May 2009 • University Paris-Dauphine, Invited Seminar, January 2008 • 6th Congress of the International Health Economics Association (iHEA), Copenhagen, July 2007
"Impact of information on the willingness to pay for relief of influenza symptoms in different delivery patterns" • Conference on Health Economics and the Pharmaceutical Industry, IDEI Toulouse, January 2008 • NBER Summer Institute, Boston, July 2006 • British-French HESG-CES workshop, London, January 2006 • 5th Congress of the International Health Economics Association (iHEA), Barcelona , July 2005 • 73rd Annual Meeting of the Swiss Society of Internal Medicine (SGIM), Basel, May 2005
"Non adherence: a rational behavior revealing patient preferences ?" • University of Tampa, Florida, Invited Seminar, September 2005 • Harvard University, Invited Seminar, July 2005 • University of Aix-Marseille, Invited Seminar, March 2005 • IRDES, Invited Seminar, Paris, Invited Seminar January 2005 • University Paris-Dauphine, Invited Seminar, January 2005 • 13th European workshop on Econometrics and Health Econometrics, Venafro, September 2004 • 5th European Conference on Health Economics (ECHE), London, September 2004 • Journées de l’AFSE (French Association of Economists), Rennes, May 2004 • British-French HESG-CES workshop, Paris, January 2004 • 4th iHEA World Congress, San Francisco, June 2003
"The effect of Health Care System and Environment on Variations in Performance and Quality of Colonoscopy in OECD countries" • lnternational Conference of the Health Policy Statistic Section (HPSS) of the American Statistical Association, Chicago, October 2003
"An analysis of longitudinal data with qualitative dependent variables. Comparison of econometric and marginal (biostatistical) approaches" • Congress of French-speaking epidemiologists (Adelf), Toulouse, September 2002
Invited discussant • 2nd Asian Workshop on Econometrics and Health Economics, Otaru, Hokkaido, December 2019 • 28th European workshop on Econometrics and Health Econometrics, Leuven, September 2019 • 1st Asian Workshop on Econometrics and Health Economics, Kyoto, December 2018 • 27th European workshop on Econometrics and Health Econometrics, Groningen, September 2018 • 26th European workshop on Econometrics and Health Econometrics, Prague, September 2017 • 25th European workshop on Econometrics and Health Econometrics, Nyborg, September 2016 • 2nd EuHEA PhD Supervisor Conference, Paris, September 2015 • 23rd European workshop on Econometrics and Health Econometrics, Munich, September 2014 • DREES, Ministry of Health, Paris, November 2013 • 22th European workshop on Econometrics and Health Econometrics, Rotterdam, September 2013 • European Health Forum Gastein, Austria, October 2012 • 21th European workshop on Econometrics and Health Econometrics, Lund, September 2012
Page 8 sur 11 Last updated: September 2020
• British-French HESG-CES workshop, Aix-en-Provence, January 2012 • 20th European workshop on Econometrics and Health Econometrics, York, September 2011 • 18th European workshop on Econometrics and Health Econometrics, Sardinia, September 2009 • 17th European workshop on Econometrics and Health Econometrics, Coimbra, September 2008 • Conference on Health Economics and the Pharmaceutical Industry, IDEI Toulouse, January 2008
Service Associate editor 2018 - present Health Economics http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1050/homepage/EditorialBoard.html
Selection committee 2019 - present Member of the Arrow Award Committee, iHEA. https://www.healtheconomics.org/page/ArrowAward
Referee Bulletin of the World Health Organization, Economic Modelling, Health Economics, Health Economics Letters, Health Policy, Health Services Research Journal, International Journal of Health Care Finance and Economics, Journal of Health Economics, Social Sciences & Medicine, The Lancet, The Geneva Papers on Risk and Insurance - Issues and Practice, The Geneva Risk and Insurance Review, The B.E. Journal of Economic Analysis & Policy
Conference Organization 2019 - present Workshop organizer of the Asian Workshop on Econometrics and Health Economics. http://www.waseda.jp/prj-wishproject/asian-wehe/index.html
Member of the iHEA Scientific Committee Review Panel for the 2019 World Congress, Zurich
Member of the iHEA Scientific Committee Review Panel for the 2017 World Congress, Boston https://www.healtheconomics.org/page/BostonCongress2017
Local organizer of the 24th European workshop on Econometrics and Health Econometrics, Paris, September 2015 (Series Organiser: Andrew Jones and Owen O’Donnell) http://www.york.ac.uk/res/herc/research/ew/index.htm
Local organizer of 19th European workshop on Econometrics and Health Econometrics, Lausanne, September 2010 (Series Organiser: Andrew Jones and Owen O’Donnell) http://www.york.ac.uk/res/herc/research/ew/index.htm
Member of the scientific committee of “Journées des Economistes de la Santé Français”, since 2010
Member of the Scientific Committee of 2009 iHEA conference, Beijing, http://www.healtheconomics.org/congress/2009/scicomm/
Member of the Scientific Committee of 2008 ECHE conference, Roma
Page 9 sur 11 Last updated: September 2020
Organization of Health Economics Seminars at the Institute of Health Economics and Management, University of Lausanne (2007 – 2009)
Organization of a series of seminars on the economics of obesity (joint organization with F Paccaud, Institute of Social and Preventive Medicine of the University Hospital) (2006)
Articles in Newspapers "Le lien entre assurance complémentaire et assurance de base freine la concurrence", Le Temps, 15 February 2006 (with B Dormont and PY Geoffard)
"Caisses maladie : pourquoi la concurrence ne fonctionne pas", Le Temps, 30 October 2006 (with RG Frank)
Consulting / Expertise 2019 - present Member of the Evaluation Committee of Paris Biotech Santé (Incubator in the Health Sector)
2018 - present Member of Cercle Galien (Health Innovation Think Tank), https://www.prixgalien.fr/cercle-galien/
2017 - present Member of the Board of Directors, French Foundation for Rare Diseases (https://fondation- maladiesrares.org/eng/our-organisation/the-board/)
2017 - present Member of the Board of Directors, ESSEC Business School
2017 The European Commission, expert evaluator for the 2017 Marie Skłodowska-Curie Individual Fellowships Call
2016 - 2017 Member of the working group LEEM-Groupama-Cabinet Tilder on the future of health insurance in France
2016 The European Commission, expert evaluator for the call on implementation research for scaling up evidence-based innovations and good practice in public health (H2020-SC1-2016-RTD)
2015 - 2018 Member of the Scientific and Medical Committee of MGEN
2014 IMS Health, Member of the Scientific Committee of a study investigating the following question: “do hyaluronic acid injections delay knee replacement surgery?”
2013 The Netherlands Organisation for Scientific Research (NWO), Independent Expert
2013 The European Commission, Directorate General for Research & Innovation, Brussels. Member of the Independent Expert Group on the Future of European Public Health Research.
Page 10 sur 11 Last updated: September 2020
2012 Atlantis Health Care , New Zealand, Steering Group Member of the project “modelling the costs of non-adherence”
2010 Haute Autorité de Santé (HAS), Paris. Member of a working group on the economic evaluation of antihypertensive drugs
2009 UNITAID – World Health Organization, Geneva, Switzerland: Establishment of guidelines for impact criteria for UNITAID strategy
2009 Carles Consultants, SOS Doctors, Paris, France. Evaluation of emergency and out-of-hours medical services in France
2007 NIVEL, the Netherlands Institute for Health Services Research. Report on cost-sharing arrangements in Switzerland.
2006 French National Cancer Institute (INCa). Evaluations of proposals.
2004 World Health Organization and International Labor Office, Geneva, Switzerland The impact of Social Health Protection Mechanisms on health Care use and catastrophic health expenditures: a case study of South Africa.
2002 Under the supervision of Pr Claude Le Pen Economic evaluations of Angiotensin Converting Enzyme (ACE) Inhibitor Trandolapril in the Treatment of Post Infarction in the US (trial-based cost effectiveness analysis)
Professional memberships 2006 -2010 Member of the committee of the Swiss Society for Health Policy (SSPS/SGGP: société suisse pour la politique de santé). http://www.sggp.ch/index.cfm. 2002 - Member of the International Health Economics Association (iHEA) 2002 - Member of the French Health Economists Association (CES) 1997-2009 Member of the committee of the health working group of HEC alumni association, Paris.
Languages French mother tongue English fluent German fair
Page 11 sur 11